About Us

Last updated on September 28th, 2019

CBDReviewer is an independent source of consumer information on products that contain cannabidiol (CBD) as the main active ingredient. Our mission is to help people identify what kinds of CBD products will work best for their personal needs, whether for pain management or general health, by examining how well these products work for others.

Every CBD product that our team reviews is given a CBDReviewer Score. This is a number between 1 and 5 that represents how poorly or how well a product treats certain symptoms or conditions. As the amount of data points we collect goes up, so does our confidence in a product’s ability to have a positive impact for others. It is then ranked against products that are known to treat similar things.

In addition to summarizing vetted survey data about the usage of a specific product, the CBDReviewer Score also reflects the sentiment of our expert Panel Reviewers — trusted, everyday people who use CBD products and who are willing to share detailed personal stories about that usage. Their stories, combined with ongoing surveys, come together to enhance the recommendations we provide.

Cannabidiol has shown promising clinical applications, but if you are new to CBD research and you intend to use CBD products for anything other than general wellness, or you are currently taking prescription or other medication, you need to consult your doctor. CBD has a low prevalence for negative side-effects, but everyone’s body is different, and cannabidiol products can interact with certain medications and cause adverse reactions.

The information on CBDReviewer does not constitute medical advice. We verify all research and information we provide with manufacturer or scientific evidence, but when it comes to dosing, always follow the recommendations from your doctor and the manufacturer. In a 2017 review of clinical data on the safety and side-effects of cannabidiol, the most commonly reported side-effects of CBD use were tiredness, diarrhea, and changes in appetite. The review concluded that though CBD has a favorable safety profile for humans, there is still much to be studied and understood about how it impacts humans long-term.